Cathepsin D Assay in Ovarian Cancer: Correlation with Pathological Features and Receptors for Oestrogen, Progesterone and Epidermal Growth Factor

Overview

Journal Br J Cancer

Specialty Oncology

Date 1991 Jul 1

PMID 1854619

Citations 6

Authors

G Scambia

P Benedetti

G Ferrandina

F Battaglia

G Baiocchi

S Mancuso

Affiliations

Soon will be listed here.

Abstract

Using an immunoradiometric assay, Cathepsin-D (Cath-D) concentrations were measured in the cytosol of 68 normal and neoplastic human ovarian tissues. Cath-D levels were higher in malignant tumours than in normal tissue samples (P less than 0.01) and benign tumours (P less than 0.01). In six out of seven cases, metastatic deposits showed Cath-D concentrations higher than the respective primary tumours. Using 12 of 17 pmols.mg-1 protein as cut-off levels, the Cath-D status (high or low) was not related to any pathological parameter. Moreover, no correlation was found between Cath-D levels and receptors for oestrogen, progesterone and epidermal growth factor. Our results indicate that ovarian tumours produce Cath-D. Further studies are needed to evaluate whether this protein could represent a prognostic factor for this neoplasia.

Citing Articles

Ultrasensitive, multiplexed chemoproteomic profiling with soluble activity-dependent proximity ligation.

Li G, Eckert M, Chang J, Montgomery J, Chryplewicz A, Lengyel E Proc Natl Acad Sci U S A. 2019; 116(43):21493-21500.

PMID: 31591248 PMC: 6815137. DOI: 10.1073/pnas.1912934116.

Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome.

Ferrandina G, Scambia G, Fagotti A, DAgostino G, Benedetti Panici P, Carbone A Br J Cancer. 1998; 78(12):1645-52.

PMID: 9862578 PMC: 2063229. DOI: 10.1038/bjc.1998.737.

Cathepsin D immunoreactivity in ovarian cancer: correlation with prognostic factors.

Athanassiadou P, Sakellariou V, Petrakakou E, Athanassiades P, Zerva C, Liossi A Pathol Oncol Res. 1998; 4(2):103-7.

PMID: 9654594 DOI: 10.1007/BF02904702.

Hormone receptors and cathepsin D levels in human breast epithelial cells transformed by chemical carcinogens and c-Ha-ras transfection.

Calaf G, Tahin Q, Alvarado M, Estrada S, Cox T, Russo J Breast Cancer Res Treat. 1994; 29(2):169-77.

PMID: 8012035 DOI: 10.1007/BF00665678.

Extracellular matrix components and proteolytic enzymes in uterine cervical carcinoma.

Bhuvarahamurthy V, Govindasamy S Mol Cell Biochem. 1995; 144(1):35-43.

PMID: 7791743 DOI: 10.1007/BF00926738.

References

Battaglia F, Scambia G, Rossi S, Panici P, Bellantone R, Polizzi G . Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement. Eur J Cancer Clin Oncol. 1988; 24(11):1685-90. DOI: 10.1016/0277-5379(88)90068-5. View

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

Morisset M, Capony F, ROCHEFORT H . The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease. Biochem Biophys Res Commun. 1986; 138(1):102-9. DOI: 10.1016/0006-291x(86)90252-4. View

Spyratos F, Maudelonde T, Brouillet J, Brunet M, Defrenne A, Andrieu C . Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet. 1989; 2(8672):1115-8. DOI: 10.1016/s0140-6736(89)91487-6. View

Thorpe S, ROCHEFORT H, Garcia M, Freiss G, Christensen I, Khalaf S . Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res. 1989; 49(21):6008-14. View

Maudelonde T, Khalaf S, Garcia M, Freiss G, Duporte J, Benatia M . Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters. Cancer Res. 1988; 48(2):462-6. View

Briozzo P, Morisset M, Capony F, Rougeot C, ROCHEFORT H . In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res. 1988; 48(13):3688-92. View

Garcia M, Lacombe M, DUPLAY H, Cavailles V, Derocq D, DELARUE J . Immunohistochemical distribution of the 52-kDa protein in mammary tumors: a marker associated with cell proliferation rather than with hormone responsiveness. J Steroid Biochem. 1987; 27(1-3):439-45. DOI: 10.1016/0022-4731(87)90338-4. View

Garcia M, Pages A, Richer G, Domergue J, Pages A, Cavalie G . Distribution of the Mr 52,000 estrogen-regulated protein in benign breast diseases and other tissues by immunohistochemistry. Cancer Res. 1986; 46(7):3734-8. View

10.

Vignon F, Capony F, Chambon M, Freiss G, Garcia M, ROCHEFORT H . Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinology. 1986; 118(4):1537-45. DOI: 10.1210/endo-118-4-1537. View

11.

Lawrence D, Pircher R, Jullien P . Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions. Biochem Biophys Res Commun. 1985; 133(3):1026-34. DOI: 10.1016/0006-291x(85)91239-2. View

12.

Maudelonde T, Martinez P, Brouillet J, Laffargue F, Pages A, ROCHEFORT H . Cathepsin-D in human endometrium: induction by progesterone and potential value as a tumor marker. J Clin Endocrinol Metab. 1990; 70(1):115-21. DOI: 10.1210/jcem-70-1-115. View

13.

Brouillet J, Theillet C, Maudelonde T, Defrenne A, Simony-Lafontaine J, Sertour J . Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness. Eur J Cancer. 1990; 26(4):437-41. DOI: 10.1016/0277-5379(90)90012-i. View

14.

Derynck R, Roberts A, Winkler M, Chen E, Goeddel D . Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell. 1984; 38(1):287-97. DOI: 10.1016/0092-8674(84)90550-6. View

15.

Imort M, Zuhlsdorf M, Feige U, Hasilik A, von Figura K . Biosynthesis and transport of lysosomal enzymes in human monocytes and macrophages. Effects of ammonium chloride, zymosan and tunicamycin. Biochem J. 1983; 214(3):671-8. PMC: 1152302. DOI: 10.1042/bj2140671. View

16.

Elangovan S, Moulton B . Progesterone and estrogen control of rates of synthesis of uterine cathepsin D. J Biol Chem. 1980; 255(15):7474-9. View

17.

Westley B, ROCHEFORT H . Estradiol induced proteins in the MCF7 human breast cancer cell line. Biochem Biophys Res Commun. 1979; 90(2):410-6. DOI: 10.1016/0006-291x(79)91250-6. View

18.

Bauknecht T, Runge M, Schwall M, Pfleiderer A . Occurrence of epidermal growth factor receptors in human adnexal tumors and their prognostic value in advanced ovarian carcinomas. Gynecol Oncol. 1988; 29(2):147-57. DOI: 10.1016/0090-8258(88)90209-0. View